Khiron Life Sciences to Present as Lead Sponsor in First CannaTech Panama Global Medical Cannabis Summit

Published: January 14, 2019

Khiron Life Sciences to Present as Lead Sponsor in First CannaTech Panama Global Medical Cannabis Summit

Khiron Life Sciences Corp., an integrated medical cannabis company with its core operations in Colombia, announced that the Company will be title sponsor of the first Cannatech Panama summit taking place February 12-13 in Panama City, Panama. Khiron will be prominently featured throughout the summit and key members of the Company’s senior medical and compliance team will deliver session presentations on global medical cannabis patient, research and compliance topics with particular impact in Latin America.

With the cannabis industry in Latin America projected to reach US$12 Billion within the next decade the highly anticipated Cannatech Panama summit brings together industry leaders from Latin America and around the world in the fields of science, medicine, finance, agri-tech, innovation and government policy to discuss the latest evidence based research, market developments and insight.

Alvaro Torres, Co-founder and Chief Executive Officer, Khiron life Sciences, said, “The Latin America cannabis industry is rapidly evolving, and as the dominant medical cannabis company in the region it is important that Khiron play a leadership role in this first ever CannaTech Panama summit. We are committed to meeting the medical needs of 1 million patients in Latin America and look forward to our global industry colleagues coming together in Panama as we work towards this goal.”

As a lead sponsor, Khiron will be featured throughout the two-day summit with events, presentations and session participation from the Company leadership team. Scheduled presentations include:

  • Dr. Maria Fernanda Arboleda, Medical Director, Khiron Life Sciences Topic: Medical Cannabis Research, Pain and Palliative Care
  • Dr. Jairo Espinoza, Founder, Latin American Institute of Neurology and Nervous System (ILANS), a Khiron Life Sciences companyTopic: Cannabis Breakthrough in Modern Medicine
  • Matt Murphy, Vice President Compliance and Security, Khiron Life Sciences Topic: Regulatory Compliance